17° Simpósio Edwaldo Camargo e 1° Congresso CancerThera





Gary A. Ulaner, M.D., Ph.D., F.A.C.N.M. is the Director of Molecular Imaging and Therapy at Hoag Family Cancer Institute.

Dr. Ulaner joined Hoag from Memorial Sloan Kettering Cancer Center, where he served as the PET/CT expert on the Breast Cancer and Myeloma Disease Management Teams. Dual board-certified in radiology and nuclear medicine, Dr. Ulaner is a nationally recognized expert in the use of targeted imaging to help direct focused cancer therapies. He leads several National Institutes of Health (NIH) clinical trials in molecular imaging and therapeutics, including two active NIH R01 grants, and has received more than $8 million in extramural funding.

Dr. Ulaner has received multiple honors throughout his career. He was elected Fellow of the American College of Nuclear Medicine, received an award for breast cancer research from the Susan Komen Foundation, and was the first Hal O’Brien Rising Star from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), among other accolades.

Dr. Ulaner has authored or co-authored more than 110 peer-reviewed manuscripts and has given more than 110 clinical presentations, both nationwide and internationally, in addition to writing the textbook Fundamentals of Oncologic PET/CT, published in both English and Spanish. He is also on the editorial boards of several leading clinical journals including: Radiology, Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, and Clinical Nuclear Medicine.

Dr. Ulaner completed his medical degree and a Ph.D. in Cancer Biology at Stanford University School of Medicine, an internship at Johns Hopkins Hospital, and his Radiology and Nuclear Medicine residencies at the University of Southern California.

Imprimir Conflito de interesse